Meticulous Research®, a premier global market research company, has published an in-depth report titled, "Tuberculosis Diagnostics Market Size, Share, Forecast, & Trends Analysis by Test Type (Mantoux, IGRA, Radiography [X-ray, CT] Molecular [NAAT, WGS, Rapid] Culture, Sputum Smear), End User (Hospital, Diagnostic Lab), Infection Stage – Global Forecast to 2031".
Download Free Research Report PDF @https://www.meticulousresearch.com/download-sample-report/cp_id=5885?utm_source=pdf&utm_medium=social+&utm_campaign=product&utm_content=13-06-2024
According to the latest publication from Meticulous Research®, the global tuberculosis diagnostics market is forecasted to reach $3.56 billion by 2031, growing at a compound annual growth rate (CAGR) of 5% from 2024 to 2031. The market’s expansion is driven by the rising prevalence of tuberculosis in low- and middle-income countries, the emergence of drug-resistant TB strains, and supportive initiatives for TB diagnosis and treatment. Additionally, efforts by governments and organizations to enhance awareness about tuberculosis are expected to open growth opportunities for market participants.
Key Market Players
Leading companies in the tuberculosis diagnostics market include F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (U.S.), Abbott Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), QIAGEN GmbH (Germany), Hologic, Inc. (U.S.), bioMérieux SA (France), Danaher Corporation (U.S.), Oxford Immunotec Ltd. (U.K.), Hain Lifescience GmbH (Germany), and Creative Diagnostics (U.S.).
Future Outlook and Market Segmentation
The tuberculosis diagnostics market is segmented based on test type, infection stage, end user, and geography. The report provides a detailed analysis at both regional and country levels.
Access Report@https://www.meticulousresearch.com/product/tuberculosis-diagnostics-market-5885?utm_source=pdf&utm_medium=social+&utm_campaign=product&utm_content=13-06-2024
•
• Test Type: The market is divided into skin test/Mantoux, radiographic tests, molecular tests, sputum smear microscopy, culture & drug resistance tests, and other test types. In 2024, the skin test/Mantoux segment is projected to hold the largest market share at 38.2%, attributed to its simplicity, low cost, and wide availability. The high use of skin tests for latent TB further boosts this segment. Skin tests are among the most economical, costing approximately USD 37, compared to the Interferon Gamma Release Assay (IGRA) at around USD 89.
• Infection Stage: The market is classified into active and latent TB. The active TB segment is expected to experience the highest CAGR from 2024 to 2031, driven by the increasing TB prevalence in low- and middle-income countries and various governmental and organizational goals to manage TB outbreaks.
• End User: Segments include diagnostic laboratories, hospitals & clinics, academic & research institutes, and other end users. Diagnostic laboratories are anticipated to register the highest CAGR, due to the adoption of advanced TB diagnostic technologies such as next-generation sequencing, and government and organizational initiatives to enhance TB awareness.
Geographical Insights
The report provides a comprehensive geographical analysis, covering North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is projected to register the highest CAGR during the forecast period, with India and China offering lucrative opportunities due to their large populations, high TB burden, and increasing healthcare investments.
Buy Now @https://www.meticulousresearch.com/Checkout/14457940?utm_source=pdf&utm_medium=social+&utm_campaign=product&utm_content=13-06-2024
Key Questions Addressed in the Report
• What is the current global revenue from tuberculosis diagnostic tests?
• What is the projected growth rate for tuberculosis diagnostic tests over the next 5-7 years?
• What are the historical market size and growth trends for tuberculosis diagnostic tests?
• What factors are influencing market growth at the regional level?
• Which market segments are gaining traction in terms of test type, infection stage, and end user?
• What are the key geographical trends and which regions offer significant growth opportunities?
• Who are the major players in the tuberculosis diagnostics market, and what are their offerings?
• What recent developments have occurred in the tuberculosis diagnostics market and how are they impacting the market globally?

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research